SIGA Receives Orphan Drug Status
The Food and Drug Administration granted Orphan Drug status to SIGA Technologies Inc.'s (SIGA) smallpox drug SIGA-246. The stock price leaped $2.23 to close at $4.95.
posted by FC Market News at 2:06 PM
0 Comments:
Post a Comment
<< Home